{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:44:27Z","timestamp":1769265867535,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"crossref","award":["82002544"],"award-info":[{"award-number":["82002544"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"crossref","award":["81760112"],"award-info":[{"award-number":["81760112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"crossref","award":["82100560"],"award-info":[{"award-number":["82100560"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"science and technology planning project of guangzhou city","award":["202102010171"],"award-info":[{"award-number":["202102010171"]}]},{"name":"chinese foundation for hepatitis prevention and control-tianqing liver disease research fund subject","award":["TQGB20200048"],"award-info":[{"award-number":["TQGB20200048"]}]},{"name":"csco-roche solid tumor research project","award":["Y-Roche2019\/2-0041"],"award-info":[{"award-number":["Y-Roche2019\/2-0041"]}]},{"name":"medical scientific research foundation of guangdong province","award":["A2021110"],"award-info":[{"award-number":["A2021110"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The mechanism of bone marrow mesenchymal stem cells (BMSCs) in treating hepatic fibrosis remains unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>TGF-\u03b21-induced hepatic stellate cell (HSC)-T6 and CCl4-induced hepatic fibrosis rats were treated with BMSCs. HSC-T6 cell activity was determined using the cell counting kit-8 assay, and the histology change was evaluated using hematoxylin and eosin and Masson staining. The expression of fibrosis markers was determined using real-time quantitative PCR, Western blotting, and immunocytochemistry. RNA sequencing (RNA-seq) was used to screen the lncRNAs involved in the effect of BMSCs in fibrosis, and the function of fibrosis-associated lncRNA in fibrosis histology change and fibrosis marker expression was investigated. The potential miRNA target of lncRNA was predicted using R software. The interaction between lncRNA and miRNA was verified using luciferase report system and RNA immunoprecipitation (RIP) in 293T and HSC-T6 cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>BMSC attenuated TGF-\u03b21-induced HSC-T6 activation and suppressed the expression of fibrosis-associated gene (MMP2, Collagen I, and \u03b1SMA) expression at the transcription and translation levels. BMSC treatment also improves hepatic fibrosis in rats with CCl4-induced fibrosis by decreasing the expression of fibrosis-associated genes and suppressing collagen deposition in the liver. RNA-seq revealed that AABR07028795.2 (lnc-BIHAA1) was downregulated in the TGF-\u03b21-induced HSC-T6 after treatment with BMSCs as compared with those in TGF-\u03b21-induced HSC-T6, and subsequently, functional analysis showed that lnc-BIHAA1 plays a beneficial role in suppressing hepatic fibrosis. Luciferase activity assay and RIP revealed that lnc-BIHAA1 interacted with the miRNA, rno-miR-667-5p, functioning as a fibrosis phenotype suppressor in TGF-\u03b21-induced HSC-T6. Moreover, overexpression of rno-miR-667-5p significantly reverses the effect of lnc-BIHAA1 on HSC-T6.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>BMSC treatment suppresses hepatic fibrosis by downregulating the lnc-BIHAA1\/rno-miR-667-5p signaling pathway in HSCs. Our results provide a scientific basis for establishing BMSCs as a biological treatment method for liver fibrosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-022-03069-7","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T10:07:09Z","timestamp":1659002829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2\/rno-miR-667-5p axis"],"prefix":"10.1186","volume":"13","author":[{"given":"Yuan","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhicheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4635-3966","authenticated-orcid":false,"given":"Nan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"issue":"8","key":"3069_CR1","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s00436-014-3972-z","volume":"113","author":"X Wang","year":"2014","unstructured":"Wang X, Hu F, Hu X, Chen W, Huang Y, Yu X. Proteomic identification of potential Clonorchis sinensis excretory\/secretory products capable of binding and activating human hepatic stellate cells. Parasitol Res. 2014;113(8):3063\u201371.","journal-title":"Parasitol Res"},{"issue":"2","key":"3069_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.yexcr.2017.02.038","volume":"352","author":"Y Huang","year":"2017","unstructured":"Huang Y, Deng X, Liang J. Modulation of hepatic stellate cells and reversibility of hepatic fibrosis. Exp Cell Res. 2017;352(2):420\u20136.","journal-title":"Exp Cell Res"},{"issue":"3","key":"3069_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.hbpd.2018.04.003","volume":"17","author":"D Ezhilarasan","year":"2018","unstructured":"Ezhilarasan D, Sokal E, Najimi M. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets. Hepatobiliary Pancreat Dis Int. 2018;17(3):192\u20137.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"10","key":"3069_CR4","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1634\/stemcells.2005-0542","volume":"24","author":"S Terai","year":"2006","unstructured":"Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells. 2006;24(10):2292\u20138.","journal-title":"Stem Cells"},{"issue":"3","key":"3069_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1042\/CBI20110325","volume":"36","author":"S Hwang","year":"2012","unstructured":"Hwang S, Hong HN, Kim HS, Park SR, Won YJ, Choi ST, et al. Hepatogenic differentiation of mesenchymal stem cells in a rat model of thioacetamide-induced liver cirrhosis. Cell Biol Int. 2012;36(3):279\u201388.","journal-title":"Cell Biol Int"},{"issue":"3","key":"3069_CR6","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1007\/s11033-019-04736-4","volume":"46","author":"DG Duman","year":"2019","unstructured":"Duman DG, Zibandeh N, Ugurlu MU, Celikel C, Akkoc T, Banzragch M, et al. Mesenchymal stem cells suppress hepatic fibrosis accompanied by expanded intrahepatic natural killer cells in rat fibrosis model. Mol Biol Rep. 2019;46(3):2997\u20133008.","journal-title":"Mol Biol Rep"},{"issue":"12","key":"3069_CR7","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.clinbiochem.2007.04.017","volume":"40","author":"MT Abdel Aziz","year":"2007","unstructured":"Abdel Aziz MT, Atta HM, Mahfouz S, Fouad HH, Roshdy NK, Ahmed HH, et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem. 2007;40(12):893\u20139.","journal-title":"Clin Biochem"},{"issue":"12","key":"3069_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861\u201374.","journal-title":"Nat Rev Genet"},{"issue":"11","key":"3069_CR9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm.3981","volume":"21","author":"M Huarte","year":"2015","unstructured":"Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21(11):1253\u201361.","journal-title":"Nat Med"},{"issue":"10","key":"3069_CR10","doi-asserted-by":"publisher","first-page":"e1506","DOI":"10.1038\/cddis.2014.466","volume":"5","author":"JY Liu","year":"2014","unstructured":"Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li YJ, et al. Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis. 2014;5(10):e1506\u201315.","journal-title":"Cell Death Dis"},{"issue":"12","key":"3069_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0188-9","volume":"50","author":"R Yarani","year":"2018","unstructured":"Yarani R, Mirza AH, Kaur S, Pociot F. The emerging role of lncRNAs in inflammatory bowel disease. Exp Mol Med. 2018;50(12):1\u201314.","journal-title":"Exp Mol Med"},{"key":"3069_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.molimm.2018.05.030","volume":"101","author":"K Liao","year":"2018","unstructured":"Liao K, Xu J, Yang W, You X, Zhong Q, Wang X. The research progress of LncRNA involved in the regulation of inflammatory diseases. Mol Immunol. 2018;101:182\u20138.","journal-title":"Mol Immunol"},{"issue":"2","key":"3069_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41419-020-2323-5","volume":"11","author":"K Zhang","year":"2020","unstructured":"Zhang K, Shi Z, Zhang M, Dong X, Zheng L, Li G, et al. Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis. Cell Death Dis. 2020;11(2):132\u201344.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3069_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41467-017-00204-4","volume":"8","author":"K Zhang","year":"2017","unstructured":"Zhang K, Han X, Zhang Z, Zheng L, Hu Z, Yao Q, et al. The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGF\u03b2 and Notch pathways. Nat Commun. 2017;8(1):144\u201359.","journal-title":"Nat Commun"},{"issue":"4","key":"3069_CR15","doi-asserted-by":"publisher","first-page":"G539","DOI":"10.1152\/ajpgi.00249.2018","volume":"316","author":"Z Dong","year":"2019","unstructured":"Dong Z, Li S, Wang X, Si L, Ma R, Bao L, et al. lncRNA GAS5 restrains CCl(4)-induced hepatic fibrosis by targeting miR-23a through the PTEN\/PI3K\/Akt signaling pathway. Am J Physiol Gastrointest Liver Physiol. 2019;316(4):G539-g550.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3069_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2017.03.008","volume":"618","author":"N Fu","year":"2017","unstructured":"Fu N, Zhao SX, Kong LB, Du JH, Ren WG, Han F, et al. LncRNA-ATB\/microRNA-200a\/\u03b2-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis. Gene. 2017;618:1\u20137.","journal-title":"Gene"},{"issue":"10","key":"3069_CR17","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/cbin.11021","volume":"42","author":"B Zhou","year":"2018","unstructured":"Zhou B, Yuan W, Li X. LncRNA Gm5091 alleviates alcoholic hepatic fibrosis by sponging miR-27b\/23b\/24 in mice. Cell Biol Int. 2018;42(10):1330\u20139.","journal-title":"Cell Biol Int"},{"issue":"24","key":"3069_CR18","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1080\/15384101.2015.1120917","volume":"14","author":"F Yu","year":"2015","unstructured":"Yu F, Lu Z, Cai J, Huang K, Chen B, Li G, et al. MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis. Cell Cycle. 2015;14(24):3885\u201396.","journal-title":"Cell Cycle"},{"issue":"3","key":"3069_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.scr.2013.08.011","volume":"11","author":"RP Meier","year":"2013","unstructured":"Meier RP, M\u00fcller YD, Morel P, Gonelle-Gispert C, B\u00fchler LH. Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence? Stem Cell Res. 2013;11(3):1348\u201364.","journal-title":"Stem Cell Res"},{"issue":"1","key":"3069_CR20","doi-asserted-by":"publisher","first-page":"17486","DOI":"10.1038\/s41598-020-74324-1","volume":"10","author":"W Xu","year":"2020","unstructured":"Xu W, Xu YN, Zhang X, Xu Y, Jian X, Chen JM, et al. Hepatic stem cell Numb gene is a potential target of Huang Qi Decoction against cholestatic liver fibrosis. Sci Rep. 2020;10(1):17486\u201399.","journal-title":"Sci Rep"},{"issue":"9","key":"3069_CR21","first-page":"9845","volume":"8","author":"SL Wang","year":"2015","unstructured":"Wang SL, Wu HM, He CZ, Yang L, Gao HJ, Yang CQ. Aldosterone and TGF-\u03b21 synergistically increase PAI-1 expression in hepatic stellate cells of rats. Int J Clin Exp Pathol. 2015;8(9):9845\u201353.","journal-title":"Int J Clin Exp Pathol"},{"issue":"Suppl 1","key":"3069_CR22","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL. Liver fibrosis\u2013from bench to bedside. J Hepatol. 2003;38(Suppl 1):S38\u201353.","journal-title":"J Hepatol"},{"key":"3069_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1756-3305-5-9","volume":"5","author":"NM El-Lakkany","year":"2012","unstructured":"El-Lakkany NM, Hammam OA, El-Maadawy WH, Badawy AA, Ain-Shoka AA, Ebeid FA. Anti-inflammatory\/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis. Parasit Vectors. 2012;5:9\u201322.","journal-title":"Parasit Vectors"},{"issue":"8","key":"3069_CR24","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/gut.2005.090449","volume":"55","author":"N Kawada","year":"2006","unstructured":"Kawada N. Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease. Gut. 2006;55(8):1073\u20134.","journal-title":"Gut"},{"issue":"3","key":"3069_CR25","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1002\/jcp.27069","volume":"234","author":"EB Bian","year":"2019","unstructured":"Bian EB, Xiong ZG, Li J. New advances of lncRNAs in liver fibrosis, with specific focus on lncRNA-miRNA interactions. J Cell Physiol. 2019;234(3):2194\u2013203.","journal-title":"J Cell Physiol"},{"issue":"4","key":"3069_CR26","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3390\/ijms21041482","volume":"21","author":"Z He","year":"2020","unstructured":"He Z, Yang D, Fan X, Zhang M, Li Y, Gu X, et al. The roles and mechanisms of lncRNAs in liver fibrosis. Int J Mol Sci. 2020;21(4):1482\u2013500.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3069_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13287-020-02083-x","volume":"12","author":"J Zhou","year":"2021","unstructured":"Zhou J, Lin Y, Kang X, Liu Z, Zhang W, Xu F. microRNA-186 in extracellular vesicles from bone marrow mesenchymal stem cells alleviates idiopathic pulmonary fibrosis via interaction with SOX4 and DKK1. Stem Cell Res Ther. 2021;12(1):96\u2013109.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"3069_CR28","doi-asserted-by":"publisher","first-page":"bio039958","DOI":"10.1242\/bio.039958","volume":"8","author":"B Xiao","year":"2019","unstructured":"Xiao B, Zhu Y, Huang J, Wang T, Wang F, Sun S. Exosomal transfer of bone marrow mesenchymal stem cell-derived miR-340 attenuates endometrial fibrosis. Biol Open. 2019;8(5):bio039958-039966.","journal-title":"Biol Open"},{"issue":"1","key":"3069_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/jcb.29170","volume":"121","author":"X Cai","year":"2020","unstructured":"Cai X, Wang L, Wang X, Hou F. miR-124a enhances therapeutic effects of bone marrow stromal cells transplant on diabetic nephropathy-related epithelial-to-mesenchymal transition and fibrosis. J Cell Biochem. 2020;121(1):299\u2013312.","journal-title":"J Cell Biochem"},{"issue":"9","key":"3069_CR30","doi-asserted-by":"publisher","first-page":"7325","DOI":"10.18632\/oncotarget.2621","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang J, Chu ES, Chen HY, Man K, Go MY, Huang XR, et al. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K\/AKT pathway. Oncotarget. 2015;6(9):7325\u201338.","journal-title":"Oncotarget"},{"issue":"1","key":"3069_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/febs.12574","volume":"281","author":"J Zheng","year":"2014","unstructured":"Zheng J, Wu C, Lin Z, Guo Y, Shi L, Dong P, et al. Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation\u2013a novel mechanism suppressing liver fibrosis. Febs j. 2014;281(1):88\u2013103.","journal-title":"Febs j"},{"issue":"1","key":"3069_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ymthe.2016.10.015","volume":"25","author":"F Yu","year":"2017","unstructured":"Yu F, Chen B, Dong P, Zheng J. HOTAIR epigenetically modulates PTEN expression via MicroRNA-29b: a novel mechanism in regulation of liver fibrosis. Mol Ther. 2017;25(1):205\u201317.","journal-title":"Mol Ther"},{"issue":"1","key":"3069_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.18632\/oncotarget.6447","volume":"7","author":"F Yu","year":"2016","unstructured":"Yu F, Lu Z, Huang K, Wang X, Xu Z, Chen B, et al. MicroRNA-17-5p-activated Wnt\/\u03b2-catenin pathway contributes to the progression of liver fibrosis. Oncotarget. 2016;7(1):81\u201393.","journal-title":"Oncotarget"},{"issue":"1","key":"3069_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bbrc.2014.02.065","volume":"446","author":"WJ Shen","year":"2014","unstructured":"Shen WJ, Dong R, Chen G, Zheng S. microRNA-222 modulates liver fibrosis in a murine model of biliary atresia. Biochem Biophys Res Commun. 2014;446(1):155\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"3069_CR35","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jhep.2018.12.016","volume":"70","author":"HC Tsay","year":"2019","unstructured":"Tsay HC, Yuan Q, Balakrishnan A, Kaiser M, M\u00f6bus S, Kozdrowska E, et al. Hepatocyte-specific suppression of microRNA-221-3p mitigates liver fibrosis. J Hepatol. 2019;70(4):722\u201334.","journal-title":"J Hepatol"},{"key":"3069_CR36","doi-asserted-by":"publisher","first-page":"10993","DOI":"10.1038\/ncomms10993","volume":"7","author":"J Hyun","year":"2016","unstructured":"Hyun J, Wang S, Kim J, Rao KM, Park SY, Chung I, et al. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Nat Commun. 2016;7:10993\u20131008.","journal-title":"Nat Commun"},{"issue":"5","key":"3069_CR37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.clinre.2019.02.003","volume":"43","author":"Y Lei","year":"2019","unstructured":"Lei Y, Wang QL, Shen L, Tao YY, Liu CH. MicroRNA-101 suppresses liver fibrosis by downregulating PI3K\/Akt\/mTOR signaling pathway. Clin Res Hepatol Gastroenterol. 2019;43(5):575\u201384.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"17","key":"3069_CR38","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1042\/BCJ20170280","volume":"474","author":"X Sun","year":"2017","unstructured":"Sun X, Haider Ali MSS, Moran M. The role of interactions of long non-coding RNAs and heterogeneous nuclear ribonucleoproteins in regulating cellular functions. Biochem J. 2017;474(17):2925\u201335.","journal-title":"Biochem J"},{"issue":"1","key":"3069_CR39","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1038\/s41467-020-19664-2","volume":"11","author":"V Simion","year":"2020","unstructured":"Simion V, Zhou H, Haemmig S, Pierce JB, Mendes S, Tesmenitsky Y, et al. A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus. Nat Commun. 2020;11(1):6135\u201350.","journal-title":"Nat Commun"},{"issue":"2","key":"3069_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.canlet.2013.06.013","volume":"339","author":"X Shi","year":"2013","unstructured":"Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339(2):159\u201366.","journal-title":"Cancer Lett"},{"issue":"1","key":"3069_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2014.06.043","volume":"547","author":"K Zhang","year":"2014","unstructured":"Zhang K, Shi ZM, Chang YN, Hu ZM, Qi HX, Hong W. The ways of action of long non-coding RNAs in cytoplasm and nucleus. Gene. 2014;547(1):1\u20139.","journal-title":"Gene"},{"issue":"5","key":"3069_CR42","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272\u201383.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"3069_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"issue":"5","key":"3069_CR44","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1159\/000472410","volume":"41","author":"F Yu","year":"2017","unstructured":"Yu F, Guo Y, Chen B, Shi L, Dong P, Zhou M, et al. LincRNA-p21 inhibits the Wnt\/\u03b2-catenin pathway in activated hepatic stellate cells via sponging MicroRNA-17-5p. Cell Physiol Biochem. 2017;41(5):1970\u201380.","journal-title":"Cell Physiol Biochem"},{"issue":"40","key":"3069_CR45","doi-asserted-by":"publisher","first-page":"14385","DOI":"10.1073\/pnas.0405913101","volume":"101","author":"TA Rand","year":"2004","unstructured":"Rand TA, Ginalski K, Grishin NV, Wang X. Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity. Proc Natl Acad Sci U S A. 2004;101(40):14385\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"27","key":"3069_CR46","doi-asserted-by":"publisher","first-page":"17897","DOI":"10.1074\/jbc.R900012200","volume":"284","author":"AJ Pratt","year":"2009","unstructured":"Pratt AJ, MacRae IJ. The RNA-induced silencing complex: a versatile gene-silencing machine. J Biol Chem. 2009;284(27):17897\u2013901.","journal-title":"J Biol Chem"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03069-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-022-03069-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03069-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T11:04:54Z","timestamp":1659006294000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-022-03069-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3069"],"URL":"https:\/\/doi.org\/10.1186\/s13287-022-03069-7","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]},"assertion":[{"value":"29 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This experiment was approved by the ethical committee of Guangzhou Forevergen Biosciences (Guangzhou, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"375"}}